Attovia Therapeutics Overview
- Year Founded
-
2022
- Status
-
Public
- Employees
-
44
- Stock Symbol
-
ATTO
- Share Price
-
$15.13
- (As of Friday Closing)
Attovia Therapeutics General Information
Description
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
Contact Information
Website
www.attovia.comCorporate Office
- 1091 Industrial Road
- Suite 310
- San Carlos, CA 94070
- United States
Corporate Office
- 1091 Industrial Road
- Suite 310
- San Carlos, CA 94070
- United States
Attovia Therapeutics Timeline
Attovia Therapeutics Stock Performance
As of 13-Nov-2026, Attovia Therapeutics’s stock price is $15.13. Its current market cap is $692M with 45.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.13 | $15.81 | $12.94 - $28.00 | $692M | 45.7M | 336K | -$5.53 |
Attovia Therapeutics Financials Summary
As of 30-Sep-2026, Attovia Therapeutics has a trailing 12-month revenue of $1.44M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| EV | 929,883 | ||
| Revenue | 1,440 | 1,350 | 0 |
| EBITDA | (84,764) | (66,450) | (42,925) |
| Net Income | (78,872) | (60,627) | (39,801) |
| Total Assets | 411,824 | 165,893 | 76,716 |
| Total Debt | 3,838 | 5,262 | 0 |
Attovia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Attovia Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Attovia Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Attovia Therapeutics Patents
Attovia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12565527-B1 | Il13 and il31 bispecific polypeptides and uses thereof | Active | 03-Sep-2024 | ||
| US-20260062475-A1 | Il13 and il31 bispecific polypeptides and uses thereof | Active | 03-Sep-2024 | ||
| US-20260209337-A1 | Il13 and il31 bispecific polypeptides and uses thereof | Pending | 03-Sep-2024 | ||
| WO-2026055142-A1 | Il13 and il31 bispecific polypeptides and uses thereof | Pending | 03-Sep-2024 | ||
| WO-2026055143-A2 | Il13-binding polypeptides and uses thereof | Pending | 03-Sep-2024 | C07K16/244 |
Attovia Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Attovia Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Attovia Therapeutics FAQs
-
When was Attovia Therapeutics founded?
Attovia Therapeutics was founded in 2022.
-
Where is Attovia Therapeutics headquartered?
Attovia Therapeutics is headquartered in San Carlos, CA.
-
What is the size of Attovia Therapeutics?
Attovia Therapeutics has 44 total employees.
-
What industry is Attovia Therapeutics in?
Attovia Therapeutics’s primary industry is Drug Discovery.
-
Is Attovia Therapeutics a private or public company?
Attovia Therapeutics is a Public company.
-
What is Attovia Therapeutics’s stock symbol?
The ticker symbol for Attovia Therapeutics is ATTO.
-
What is the current stock price of Attovia Therapeutics?
As of 13-Nov-2026 the stock price of Attovia Therapeutics is $15.13.
-
What is the current market cap of Attovia Therapeutics?
The current market capitalization of Attovia Therapeutics is $692M.
-
What is Attovia Therapeutics’s current revenue?
The trailing twelve month revenue for Attovia Therapeutics is $1.44M.
-
What is Attovia Therapeutics’s annual earnings per share (EPS)?
Attovia Therapeutics’s EPS for 12 months was -$5.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
